PINNACLE ASSOCIATES LTD - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$4,255,006
-25.1%
119,355
-3.1%
0.08%
-20.2%
Q2 2023$5,683,031
+12.1%
123,196
-2.5%
0.10%
-4.8%
Q1 2023$5,068,520
-14.8%
126,397
-1.6%
0.10%
-20.0%
Q4 2022$5,950,440
+10.2%
128,436
-1.5%
0.13%
+4.8%
Q3 2022$5,401,000
-32.5%
130,418
-2.7%
0.12%
-28.7%
Q2 2022$7,998,000
-19.2%
134,058
-1.6%
0.17%
-0.6%
Q1 2022$9,897,000
-16.9%
136,279
-3.7%
0.18%
-14.6%
Q4 2021$11,905,000
-7.3%
141,574
-0.5%
0.20%
-13.5%
Q3 2021$12,839,000
-8.1%
142,356
-2.8%
0.24%
-6.3%
Q2 2021$13,970,000
-15.6%
146,515
+0.8%
0.25%
-19.7%
Q1 2021$16,543,000
-24.5%
145,290
-8.3%
0.32%
-29.2%
Q4 2020$21,921,000
+59.1%
158,355
-5.6%
0.44%
+36.1%
Q3 2020$13,782,000
+1.1%
167,686
-3.7%
0.33%
-2.7%
Q2 2020$13,626,000
+71.5%
174,199
-2.6%
0.34%
+39.4%
Q1 2020$7,943,000
-12.4%
178,771
-15.8%
0.24%
+21.1%
Q4 2019$9,071,000
+190.5%
212,387
+190.9%
0.20%
+168.9%
Q3 2019$3,123,00073,0070.07%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders